Inactive Instrument

Calendar TapImmune Inc. OTC Bulletin Board

Equities

TPIV

US8760334081

Chart calendar TapImmune Inc.

26496d6a998308d752.cS6uFup-yhIdBuWgWmeu4CiunarizxLOUDGPxp1VzgI.QmvGT9Iks35CNZLmaS_qk1nJ7O6qrVX9PmO7qvMYjXJEHJ1V0zKealh0ig~e7c78d665e8b4ebd09a71f2b86f1b548

Upcoming events on TapImmune Inc.

06/06/2024 07:30 pm Annual General Meeting
08/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
13/03/2025 Q4 2024 Earnings Release (Projected)
08/05/2025 Q1 2025 Earnings Release (Projected)

Past events on TapImmune Inc.

16/05/2024 01:45 am Q1 2024 Earnings Release
02/04/2024 Hematologic Malignancies Global Summit
26/03/2024 07:30 pm H.C. Wainwright Cell Therapy Virtual Conference
26/03/2024 03:15 am Q4 2023 Earnings Release
10/01/2024 Non Dilutive Funding Summit
08/01/2024 Biotech Showcase
10/11/2023 03:30 am Q3 2023 Earnings Release
13/09/2023 06:00 pm H.C. Wainwright Global Investment Conference
15/08/2023 02:00 am Q2 2023 Earnings Release
06/06/2023 06:30 pm Annual General Meeting
22/03/2023 05:40 pm Q4 2022 Earnings Release
11/11/2022 02:35 am Q3 2022 Earnings Release
15/09/2022 06:50 pm Cantor Fitzgerald Cell & Gene Therapy Conference
12/08/2022 01:52 am Interim 2022 Earnings Release
24/05/2022 06:30 pm Annual General Meeting
13/05/2022 04:30 pm Q1 2022 Earnings Release
06/05/2022 06:15 am International Society for Cell & Gene Therapy Meeting - Abstract Number : 506
06/05/2022 06:15 am International Society for Cell & Gene Therapy Meeting - Abstract Number : 936
06/05/2022 06:15 am International Society for Cell & Gene Therapy Meeting - Abstract Number : 515
06/05/2022 06:15 am International Society for Cell & Gene Therapy Meeting - Abstract Number : 937

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,21
0,00
-
0,47
0,48
-3.46%
1,24
0,00
-
9,01
9,00
0.15%
0,00



0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00



0,00

EBIT
Million USD
Released
Forecast
Spread
-22,5
-23,2
2.92%
-28,9
-27,8
-3.86%
-39,5
-40,5
2.49%
0,00
0,00
-
0,00



-18,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-21,4
-22,2
3.26%
-28,7
-27,7
-3.56%
-41,9
-42,3
0.95%
0,00
0,00
-
-14,0



-17,4

Net income
Million USD
Released
Forecast
Spread
-21,4
-22,2
3.26%
-28,7
-27,7
-3.56%
-41,9
-42,3
0.95%
0,00
0,00
-
-8,24



-17,4

EPS
USD
Released
Forecast
Spread
-4,70
-4,86
3.29%
-6,10
-5,90
-3.39%
-5,50
-5,73
3.93%
-3,58
-3,60
0.56%
0,00



-1,28

Announcement Date12/03/2009/03/2117/03/2222/03/2325/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,96
0,00
-
0,79
2,50
-68.38%
3,95
0,27
1381.07%
3,31
0,00
-
1,24
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-9,79
-11,2
12.55%
-9,28
-8,72
-6.46%
-7,02
-11,3
37.7%



-2,55
-2,45
-4.21%

-2,57


-5,29


-7,93

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-9,91
-11,2
11.25%
-9,24
-8,74
-5.81%
-6,92
-10,9
36.23%



-2,39
-2,26
-6.02%

-2,42


-5,17


-7,53

Net income
Million USD
Released
Forecast
Spread
-9,91
-11,2
11.25%
-9,24
-8,74
-5.81%
-6,92
-10,9
36.23%



-2,39
-2,26
-6.02%

-2,42


-5,17


-7,53

EPS
USD
Released
Forecast
Spread
-1,20
-1,33
10%
-1,10
-1,05
-4.76%
-0,80
-1,30
38.46%
-3,27
-1,00
-227%
-0,27
-0,25
-8%

-0,27


-0,37


-0,39

Announcement Date13/05/2211/08/2210/11/2222/03/2315/05/24---
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW